Linda McDonough

Linda McDonough is a veteran hedge fund analyst who loves to break down company financial statements and identify market inefficiencies to uncover big opportunities.  She believes in a boots-on-the-ground approach that includes surveying customers, interviewing company executives, or doing whatever it takes to see what others don't.

She's now brought her experience as a hedge fund analyst to subscribers of her Profit Catalyst Alert service. Her system identifies small- and mid-cap stocks that are about to move due to catalytic events that few others can identify...until it's too late. These events often times result in massive gains for her followers.

Analyst Articles

Jazz is up almost 30% since my February 2017 recommendation. Recent commentary from the FDA regarding branded companies thwarting new generic entrants may drag the stock down. I'll look for a better entry point to re-visit this name. Read More

Sell to close the June 15, 2018 call on Abbvie (NYSE: ABBV) with a strike price of $105 at $4.20 or higher for a swift 50% gain. Symbol (ABBV180615C105). It’s a beautiful thing when an options trade suggestion works out almost exactly as planned. Abbvie boosted investor confidence regarding… Read More